Clinical trial
ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation…
NCT00231426 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00231426 |
|---|---|
| Title | ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations |
| Official title | Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICDs Study |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tachyarrhythmia |
| Intervention type | Device |
| Interventions | ICD |
| Start date | Jun 1, 2003 |
| Completion | Nov 1, 2005 |
| First posted | Oct 4, 2005 |
| Last update posted | Nov 22, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: